Bibliometric analysis of emerging trend and top 100 most cited articles in primary central nervous system lymphoma
Geng, Y.; Liu, Y.; Wang, Y.; Li, X.
Show abstract
BackgroundOver the past thirty years, numerous studies on primary central nervous system lymphoma (PCNSL) have been conducted, encompassing epidemiology, diagnosis, treatment, and mechanisms. However, no bibliometric analysis has been performed in this field. Therefore, we conducted a bibliometric analysis to elucidate the evolution and current status of PCNSL research and identify the most-cited articles across various disciplines. Material and MethodsLiterature published between January 1992 and June 2024 in the Web of Science Core Collection (WoSCC) was extracted and classified. Three platforms (R-bibliometrix, VOSviewer, and Citespace) were used for the bibliometric analysis. Negative binomial regression was employed to establish a model for the risk ratio of citation. ResultsA total of 1,798 publications were included in the analysis. The annual number of publications has shown a steady increase over time. The United States emerged as the leading country in terms of both the number of publications and total citations. Among individual researchers, Hoang-Xuan Khe from Sorbonne University was the most prolific in terms of publication count, while Lisa M. DeAngelis from Memorial Sloan Kettering Cancer Center received the highest number of citations. The study titled "Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma" was identified as the most cited work in this field. Keyword analysis indicated that immune therapy and non-invasive diagnosis are the primary focal points of current research. Among the top 100 most-cited articles, interventional studies demonstrated a higher citation ratio (RR = 1.357, 95% CI 1.044-1.764, P=0.023), whereas chemoradiotherapy studies exhibited a lower citation ratio (RR = 0.763, 95% CI 0.603-0.965, P=0.024). ConclusionResearch hotspots and trends in PCNSL were identified and explored using bibliometric and visual methods. The highly cited articles across multiple disciplines related to PCNSL may help generate high-quality research ideas, particularly in the fields of immunotherapy and non-invasive diagnosis.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Knowledge Mapping of Alternative Splicing of Cancer From 2012 to 2021: A Bibliometric Analysis 92%
- Establishment of primary renal lymphoma model and the clinical relevance 91%
- Establishment of a prognosis prediction model based on pyroptosis-related signatures associated with the immune microenvironment and molecular heterogeneity in clear cell renal carcinoma 91%
Similar papers in this journal
- MUC17 mutations and methylation are associated with poor prognosis in adult-type diffuse glioma patients 92%
- Cerebral Microvascular Injury in Severe COVID-19 88%
- Comparative Efficacy and Safety of Tenecteplase and Alteplase in Acute Ischemic Stroke: A Pairwise and Network Meta-analysis of Randomized Controlled Trials 87%
Similar papers in this journal
- Compassionate use of recombinant human IL-7-hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma 92%
- Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancer 91%
- Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer 91%
Similar papers in this journal
- Immune Classification of Clear Cell Renal Cell Carcinoma 92%
- Candidate genes associated with neurological manifestations of COVID-19: Meta-analysis using multiple computational approaches 91%
- Predicting Prognosis and IDH Mutation Status for Patients with Lower-Grade Gliomas Using Whole Slide Images 91%
Similar papers in this journal
- A Large Scale Multi-dataset Investigation of Brain Metastases Distribution Based on Primary Cancer Type 92%
- Detection of local microvascular proliferation in IDH wild-type Glioblastoma using relative Cerebral Blood Volume 91%
- Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.